148
  Mrv0541 02231214282D          

  9  8  0  0  0  0            999 V2000
    5.6655   -0.0784    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9509    1.1592    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.5220    0.3341    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.0930    0.3341    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.8075   -0.9034    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.2365   -0.0784    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5220    1.1592    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8075   -0.0784    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9509    0.3341    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  9  1  0  0  0  0
  2  9  2  0  0  0  0
  3  6  1  0  0  0  0
  3  7  1  0  0  0  0
  3  8  1  0  0  0  0
  4  8  1  0  0  0  0
  5  8  2  0  0  0  0
  6  9  1  0  0  0  0
M  END
> <DRUGBANK_ID>
DB00148

> <DRUG_GROUPS>
approved; nutraceutical

> <GENERIC_NAME>
Creatine

> <SYNONYMS>
(alpha-Methylguanido)acetic acid; (N-methylcarbamimidamido)acetic acid; (Î±-methylguanido)acetic acid; alpha-Methylguanidino acetic acid; Creatin; Kreatin; Methylglycocyamine; N-(aminoiminomethyl)-N-methylglycine; N-Amidinosarcosine; N-Methyl-N-guanylglycine

> <CHEMICAL_FORMULA>
C4H9N3O2

> <MOLECULAR_WEIGHT>
131.1332

> <EXACT_MASS>
131.069476547

> <IUPAC_NAME>
2-(1-methylcarbamimidamido)acetic acid

> <IUPAC_TRADITIONAL_NAME>
creatine

> <INCHI_IDENTIFIER>
InChI=1S/C4H9N3O2/c1-7(4(5)6)2-3(8)9/h2H2,1H3,(H3,5,6)(H,8,9)

> <INCHI_KEY>
InChIKey=CVSVTCORWBXHQV-UHFFFAOYSA-N

> <SMILES>
CN(CC(O)=O)C(N)=N

> <JCHEM_ACCEPTOR_COUNT>
5

> <JCHEM_DONOR_COUNT>
3

> <JCHEM_ACIDIC_PKA>
3.5

> <JCHEM_BASIC_PKA>
12.43

> <JCHEM_PHYSIOLOGICAL_CHARGE>
0

> <ALOGPS_LOGP>
-1.6

> <JCHEM_LOGP>
-2.9

> <ALOGPS_LOGS>
-1.5

> <JCHEM_POLARIZABILITY>
12.17

> <JCHEM_POLAR_SURFACE_AREA>
90.41

> <JCHEM_REFRACTIVITY>
42.01

> <JCHEM_ROTATABLE_BOND_COUNT>
2

> <ALOGPS_SOLUBILITY>
4.11e+00 g/l __ 

$$$$
